Indications for Short-Term Benzodiazepine Prescription

Primary Indications

Benzodiazepines should be prescribed short-term (ideally 2-4 weeks maximum, not exceeding 4 months) for severe anxiety disorders, acute stress reactions, short-term insomnia, acute alcohol withdrawal, acute seizure management, and skeletal muscle spasm, with careful attention to dose minimization and patient selection to prevent dependence, as recommended by The Lancet Psychiatry 1
Benzodiazepines are indicated for transient or short-term insomnia, with prescriptions limited to a few days, occasional/intermittent use, or courses not exceeding 2 weeks, according to the American Academy of Sleep Medicine 2
For acute seizure control: IV benzodiazepines (lorazepam preferred over diazepam when available) should be administered when IV access is available, as suggested by PLoS Medicine 3

The effectiveness of benzodiazepines beyond 4 months has not been assessed by systematic clinical studies, and physicians should periodically reassess usefulness for individual patients, with guidelines emphasizing that benzodiazepines should be used for the shortest duration possible, ideally less than 2-4 weeks, to minimize risk of dependence and withdrawal symptoms, as noted by The Lancet Psychiatry 1
Sudden cessation can lead to physical and psychological withdrawal symptoms; patients treated long-term should be offered careful tapering and support, as recommended by The Lancet Psychiatry 1
Avoid combination with opioids: Taking benzodiazepines with opioids increases risk of dangerous respiratory depression and overdose, as warned by The Lancet Psychiatry 1
Monitor for paradoxical effects: Benzodiazepines can cause paradoxical excitement with forensic implications, and complex behaviors including sleepwalking, eating, driving, and sexual behavior, as reported by the American Academy of Sleep Medicine 2

The American Academy of Sleep Medicine suggests that the selection of a benzodiazepine should be based on the patient's symptom profile, treatment goals, previous treatment responses, patient preference, cost, availability of other treatments, comorbid conditions, contraindications, interactions with other drugs, and side effects 4

Lorazepam is effective for anxiety, insomnia due to anxiety, temporary stress conditions, and acute delirium, with a high affinity for GABA-A receptors, and is associated with a lower risk of sedation, according to the Annals of Oncology 5
Temazepam has an intermediate affinity for GABA-A receptors, is used for short-term insomnia, and has a moderate half-life, making it suitable for treating sleep disorders, as recommended by the Journal of Clinical Sleep Medicine 6

For acute delirium, lorazepam 1 mg sublingually or intravenously (up to 2 mg maximum) is recommended, with caution due to potential side effects such as delirium, somnolence, and dizziness, as noted in the Annals of Oncology 5, 7
Temazepam dosing starts at 7.5 mg for mild sedation, suitable for elderly or weakened patients, and can be increased to 15-30 mg for more pronounced sedative effects, according to the Journal of Clinical Sleep Medicine 6

The American Academy of Sleep Medicine guidelines suggest that benzodiazepines should be used for the shortest duration possible, ideally less than 2-4 weeks, to minimize the risk of dependence and withdrawal symptoms 4

The American Society of Clinical Oncology recommends benzodiazepines as the treatment of choice for acute alcohol or benzodiazepine withdrawal, and for acute delirium with severe agitation, in patients at risk to themselves or others 8, 9
The American College of Clinical Pharmacology advises against using benzodiazepines in patients with severe pulmonary insufficiency, severe liver disease, or myasthenia gravis, unless the patient is imminently dying 8, 9

The American Geriatrics Society recommends using lower starting doses of lorazepam (1-2 mg/day divided, or 0.25-0.5 mg for acute situations) in elderly patients, and adjusting as needed 8, 9
The Society of Critical Care Medicine suggests that benzodiazepine clearance is reduced in patients with hepatic impairment, and that the dose should be reduced accordingly 10

The American Academy of Sleep Medicine warns against combining benzodiazepines with opioids, due to the increased risk of dangerous respiratory depression and overdose 8, 9
The American Society of Health-System Pharmacists advises caution when using high-dose olanzapine with benzodiazepines, due to the risk of fatal outcomes 8, 9

The American Psychiatric Association notes that benzodiazepines can worsen delirium, and recommends using them only when necessary, in the lowest effective dose, and for the shortest period possible 8, 9
The Gerontological Society of America highlights the importance of considering age-related pharmacokinetic changes when prescribing benzodiazepines to elderly patients, including decreased clearance and prolonged effects 10